Detalhe da pesquisa
1.
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study.
Lancet Oncol
; 22(7): 1034-1046, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34143970
2.
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice.
Eur J Cancer
; 186: 172-184, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086595
3.
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.
Lancet Oncol
; 12(11): 1045-52, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21937277
4.
Pattern of Care and Outcomes of Adolescent and Young Adults with Lymphoma Treated in the Rhône-Alpes Region.
J Adolesc Young Adult Oncol
; 8(6): 684-696, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31411521
5.
Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study.
J Clin Oncol
; 34(7): 706-13, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26755507